 |
|
Managing dyslipidemia in chronic kidney disease: a comprehensive overview of evidence and recommendations
Ji Yoon Kim, Suk Min Chung, Nam Hoon Kim
Korean J Intern Med. 2025;40(6):876-889. Published online 2025 Oct 31 DOI: https://doi.org/10.3904/kjim.2025.099
|
|
Citations to this article as recorded by
 Analysis of Risk Factors for Hyperlipidemia after Liver Transplantation: A Single-Center Retrospective Study
天明 赵
Advances in Clinical Medicine.2026; 16(04): 639. CrossRef The Diagnostic Value of sdLDL-C for Acute Coronary Syndrome with Coexisting Hypertension and Carotid Atherosclerosis in Northeast China
Jiayu Li, Zhe Dong, Dandan Wang, Jing Cui
International Journal of General Medicine.2026; Volume 19: 1. CrossRef Lipid Disorders in Patients with Renal Failure: Role in Cardiovascular Events and Progression of Chronic Kidney Disease
Maria-Daniela Tanasescu, Andrei-Mihnea Rosu, Alexandru Minca, Maria-Mihaela Grigorie, Delia Timofte, Dorin Ionescu
Life.2026; 16(6): 986. CrossRef Proteomic Mendelian randomization and machine learning reveal causal plasma biomarkers in cardiorenal comorbidity
HaiQuan Huang, Wenkang Liu, YaNan Yan, Juan Cao, JiePeng Wang, ChaoYi Fang
Renal Failure.2026;[Epub] CrossRef Clinical evaluation of rituximab combined with ACE inhibitors and statins in refractory nephrotic syndrome: associations with proteinuria, lipid profiles, and podocyte-related biomarkers
Mengmeng Zhuang, Minguo Chen
Frontiers in Pharmacology.2026;[Epub] CrossRef Renal Replacement Therapy in Cardiovascular-Kidney-Metabolic Syndrome: Challenges for Dialytic Therapies and Kidney Transplantation
Mahtab Mashayekhi, Jasjot Bhullar, Zohreh Gholizadeh Ghozloujeh, Sayna Norouzi, Khalil Pathan, Amir Abdipour
Cardiorenal Medicine.2026; 16(1): 357. CrossRef Association between Lipid Abnormalities and Renal Dysfunction in Esophageal Cancer Patients: A Cross-Sectional Study
琳欣 李
Advances in Clinical Medicine.2026; 16(08): 435. CrossRef
|